PlexusDx recommends viewing semaglutide as part of an ongoing metabolic management strategy, not a temporary intervention, to maintain results long-term
Life Sci., 54: 1316-1329 Cordido et al (1993), Massive growth hormone (GH) discharge in obese subjects after the combined administration of GH-releasing hormone and GHRP-6: evidence for a marked somatotroph secretory capability in obesity
Moreover, a mild increased vascularity and patchy chronic inflammatory cell infiltrate in the connective tissue was observed in all our cases of MM and, interestingly, few pigmented dendritic melanocytes in the basal layer of the epithelium (cases 5 and 8) were observed
doi:10.1007/s00535-023-02014-6
There can be some significant side effects, Azar said
Usually taken daily while following a structured meal plan